26 Facts About Trazodone

1.

Trazodone, sold under many brand names, is an antidepressant medication.

FactSnippet No. 626,386
2.

Trazodone was approved for medical use in the United States in 1981.

FactSnippet No. 626,387
3.

Trazodone has minimal anticholinergic activity, it was especially welcomed as a treatment for geriatric patients with depression when it first became available.

FactSnippet No. 626,388
4.

Trazodone is often used in the treatment of anxiety disorders such as generalized anxiety disorder, panic disorder, post-traumatic stress disorder, and obsessive–compulsive disorder.

FactSnippet No. 626,389
5.

Trazodone is often used as an alternative to benzodiazepines in the treatment of anxiety disorders.

FactSnippet No. 626,390

Related searches

United States Italy
6.

Trazodone was the second-most prescribed agent for insomnia in the early 2000s, though most studies of trazodone for treatment of sleep disturbances have been in depressed individuals.

FactSnippet No. 626,391
7.

Trazodone is provided as the hydrochloride salt and is available in the form of 50mg, 100mg, 150mg, and 300mg oral tablets.

FactSnippet No. 626,392
8.

Trazodone is not recommended for use during the initial recovery phase of myocardial infarction.

FactSnippet No. 626,393
9.

Trazodone is associated with increased risk of falls in older adults.

FactSnippet No. 626,394
10.

Trazodone appears to be relatively safer than TCAs, MAOIs, and a few of the other second-generation antidepressants in overdose situations, especially when it is the only agent taken.

FactSnippet No. 626,395
11.

Trazodone is metabolized by several liver enzymes, including CYP3A4, CYP2D6, and CYP1A2.

FactSnippet No. 626,396
12.

Trazodone is a mixed agonist and antagonist of various serotonin receptors, antagonist of adrenergic receptors, weak histamine H1 receptor antagonist, and weak serotonin reuptake inhibitor.

FactSnippet No. 626,397
13.

Trazodone is a 5-HT1A receptor partial agonist similarly to buspirone and tandospirone but with comparatively greater intrinsic activity.

FactSnippet No. 626,398
14.

Trazodone lacks any affinity for the muscarinic acetylcholine receptors, so does not produce anticholinergic side effects.

FactSnippet No. 626,399
15.

Trazodone is known to be extensively metabolized by the liver via hydroxylation, N-oxidation, and N-dealkylation.

FactSnippet No. 626,400
16.

Trazodone is a triazolopyridine derivative and a phenylpiperazine that is structurally related to nefazodone and etoperidone, each of which are derivatives of it.

FactSnippet No. 626,401
17.

Trazodone was developed in Italy, in the 1960s, by Angelini Research Laboratories as a second-generation antidepressant.

FactSnippet No. 626,402
18.

Trazodone was patented and marketed in many countries all over the world.

FactSnippet No. 626,403
19.

Trazodone is the generic name of the drug and its INN, BAN, and DCF, while trazodone hydrochloride is its USAN, USP, BANM, and JAN.

FactSnippet No. 626,404
20.

Trazodone has been marketed under a large number of brand names throughout the world.

FactSnippet No. 626,405
21.

Trazodone has been reported to be effective in the treatment of sleep apnea.

FactSnippet No. 626,406
22.

Trazodone has been studied as an adjunctive therapy in the treatment of schizophrenia.

FactSnippet No. 626,407
23.

Trazodone has been reported to be effective in treating antipsychotic-related extrapyramidal symptoms such as akathisia.

FactSnippet No. 626,408
24.

Trazodone has been studied and reported to be effective in the treatment of bulimia, but there is limited evidence to support this use.

FactSnippet No. 626,409
25.

Trazodone might be effective in the treatment of adjustment disorder.

FactSnippet No. 626,410

Related searches

United States Italy
26.

Trazodone has been used to reduce anxiety and stress, to improve sleep, and to produce sedation in dogs and cats in veterinary medicine.

FactSnippet No. 626,411